Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2003 | |
| Cash Flows From Operating Activities | |
| Net Income | -86 |
| Depreciation Amortization | 1 |
| Other Working Capital | -3 |
| Other Operating Activity | 20 |
| Operating Cash Flow | $-68 |
| Cash Flows From Investing Activities | |
| PPE Investments | -6 |
| Purchase Of Investment | -15 |
| Investing Cash Flow | $-21 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | -10 |
| Financing Cash Flow | $-10 |
| Beginning Cash Position | 234 |
| End Cash Position | 135 |
| Net Cash Flow | $-99 |
| Free Cash Flow | |
| Operating Cash Flow | -68 |
| Capital Expenditure | -6 |
| Free Cash Flow | -75 |